Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The process of structure-based drug design.

Amy C Anderson1

  • 1Dartmouth College, Department of Chemistry, Burke Laboratories, Hanover, NH 03755, USA. amy.c.anderson@dartmouth.edu

Chemistry & Biology
|October 3, 2003
PubMed
Summary

Structure-based drug design leverages genomic and structural data for discovering new drug leads. This review outlines the process, from target selection to lead evaluation, using AmpC beta-lactamase as a case study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative pharmacokinetics of seven propargyl-linked antifolate antibiotics in the mouse.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2025
Same author

Structural and Functional Studies of Bacterial Enolase, a Potential Target against Gram-Negative Pathogens.

Biochemistry·2019
Same author

Pharmaceutical analysis of a novel propargyl-linked antifolate antibiotic in the mouse.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2017
Same author

Direct Substitution of Arylalkynyl Carbinols Provides Access to Diverse Terminal Acetylene Building Blocks.

Organic letters·2016
Same author

MRSA Isolates from United States Hospitals Carry dfrG and dfrK Resistance Genes and Succumb to Propargyl-Linked Antifolates.

Cell chemical biology·2016
Same author

OSPREY Predicts Resistance Mutations Using Positive and Negative Computational Protein Design.

Methods in molecular biology (Clifton, N.J.)·2016

Area of Science:

  • Medicinal Chemistry
  • Structural Biology
  • Pharmacology

Background:

  • Structure-based drug design (SBDD) is a rapidly advancing field.
  • Genomic, proteomic, and structural data provide numerous targets for drug discovery.
  • Recent successes highlight the potential of SBDD.

Purpose of the Study:

  • To review the process of structure-based drug design.
  • To outline key considerations in target selection and structure evaluation.
  • To discuss methods for drug lead discovery and evaluation.

Main Methods:

  • Literature review of SBDD principles and applications.
  • Case study analysis of drug design for AmpC beta-lactamase.
  • Summary of critical decision points in the SBDD workflow.

Main Results:

  • The review details the systematic approach to SBDD.
  • It emphasizes the importance of target and structure evaluation.
  • The case study illustrates practical application of SBDD principles.

Conclusions:

  • SBDD is a powerful strategy for identifying novel drug candidates.
  • Effective target selection and lead optimization are crucial for success.
  • The review provides a framework for understanding and applying SBDD.

Related Experiment Videos